Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2023 Filed Feb 13, 2023 23:19 UTC |
Kurtz Ronald M MDDirector · President & CEO
|
GrantCommon Stock | 40,000 | $12.50 | $500,000.00 |
DisclosureSEC source: 0001209191-23-008846 · doc4.xml · nonDerivative · entry 1 Kurtz Ronald M MD · CIK 0001295469 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:26 UTC |
Fountain TamaraDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004409 · doc4.xml · nonDerivative · entry 2 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,508 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F3 · shares: Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean January 19, 2023. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:26 UTC |
Fountain TamaraDirector
|
GrantCommon Stock | 19,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004409 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,196 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of January 2, 2022. Consequently, one third of the RSUs subject to the award were settled immediately upon the date of grant. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:05 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 107,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056565 · doc4.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 595,409 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F3 · ownership.nature: Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:05 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 316,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056565 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 258,390 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · ownership.nature: Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:47 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 107,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045434 · doc4.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 488,173 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F3 · ownership.nature: Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:47 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 316,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045434 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 575,084 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · ownership.nature: Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 22:22 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 126,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035584 · doc4.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 380,937 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F3 · ownership.nature: Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 22:22 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035584 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 891,778 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · ownership.nature: Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:24 UTC |
Tammenoms Bakker JulietDirector
|
GrantCommon Stock | 10,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034396 · doc4.xml · nonDerivative · entry 1 Tammenoms Bakker Juliet · CIK 0001431159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,708 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:25 UTC |
Warner Robert KeithDirector
|
GrantCommon Stock | 8,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034397 · doc4.xml · nonDerivative · entry 1 Warner Robert Keith · CIK 0001874373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,002 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:23 UTC |
PALMISANO ROBERT JDirector
|
GrantCommon Stock | 8,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034395 · doc4.xml · nonDerivative · entry 1 PALMISANO ROBERT J · CIK 0001138646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,002 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:22 UTC |
Maniar ShwetaDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034394 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,508 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:21 UTC |
LINK WILLIAM J PHDDirector
|
GrantCommon Stock | 10,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034391 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,458 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:19 UTC |
Andrews JulieDirector
|
GrantCommon Stock | 8,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034386 · doc4.xml · nonDerivative · entry 1 Andrews Julie · CIK 0001550508 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,627 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:20 UTC |
Corley Jesse AndersonDirector
|
GrantCommon Stock | 10,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034388 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,358 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:06 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-018791 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,266,778 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock ("Common Stock") to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · balance_after: Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock ("IPO"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO. F1 · ownership.nature: Represents a distribution not for value of shares of the Issuer's Common Stock ("Common Stock") to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · ownership.nature: Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock ("IPO"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO. Read SEC document |
| May 17, 2022 Filed Jun 8, 2022 20:07 UTC Amendment |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 126,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035013 · doc4a.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 253,958 F1 · security: This Form 4 is being filed to report the acquisition of shares by Flying L Partners, II LLC, of which the Reporting Person is a managing member, and the Reporting Person's direct holdings, each inadvertently omitted from the Form 4 filed May 19, 2022. F2 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F3 · ownership.nature: Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 01:13 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 375,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011520 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,641,778 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock ("Common Stock") to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · balance_after: Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock ("IPO"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO. F1 · ownership.nature: Represents a distribution not for value of shares of the Issuer's Common Stock ("Common Stock") to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F2 · ownership.nature: Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock ("IPO"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO. Read SEC document |
| March 15, 2022 Filed Jun 8, 2022 20:04 UTC Amendment |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 126,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034997 · doc4a.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,979 F1 · security: This Form 4 is being filed to report the acquisition of shares by Flying L Partners, II LLC, of which the Reporting Person is a managing member, and the Reporting Person's direct holdings, each inadvertently omitted from the Form 4 filed March 17, 2022. F2 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC ("RxSight I") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I. F3 · ownership.nature: Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:26 UTC |
Maniar ShwetaDirector
|
GrantCommon Stock | 19,196 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000893 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,196 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of January 3, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 22:02 UTC |
Corley Jesse AndersonDirector
|
PurchaseCommon Stock | 8,150 | $12.49 | $101,752.75 |
DisclosureSEC source: 0000899243-21-045279 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,009 Read SEC document |
| August 05, 2021 Filed Aug 5, 2021 23:27 UTC |
Kurtz Ronald M MDDirector · See Remarks
|
PurchaseCommon Stock | 3,638 | $13.85 | $50,378.30 |
DisclosureSEC source: 0000899243-21-031814 · doc4.xml · nonDerivative · entry 2 Kurtz Ronald M MD · CIK 0001295469 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 804,610 F2 · price: Represents the weighted average share price of an aggregate total of 3,638 shares purchased in the price range of $13.50 to $14.00 by Cricklewood LP. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · ownership.nature: Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:54 UTC |
Goldshleger IlyaChief Operating Officer
|
PurchaseCommon Stock | 1,372 | $13.69 | $18,782.68 |
DisclosureSEC source: 0000899243-21-031997 · doc4.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,372 F2 · price: Represents the weighted average share price of an aggregate total of 1,372 shares purchased in the price range of $13.61 to $13.9599 by the Reporting Person's spouse. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F3 · balance_after: The shares reported as beneficially held include a de minimus adjustment of 0.366 shares due to the rounding up of fractional shares Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:54 UTC |
Goldshleger IlyaChief Operating Officer
|
PurchaseCommon Stock | 1,000 | $14.49 | $14,492.20 |
DisclosureSEC source: 0000899243-21-031997 · doc4.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: Represents the weighted average share price of an aggregate total of 1,000 shares purchased in the price range of $14.46 to $14.60 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:53 UTC |
Weinberg EricChief Commercial Officer
|
PurchaseCommon Stock | 9 | $14.90 | $134.10 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 5 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 925 Read SEC document |
| August 04, 2021 Filed Aug 7, 2021 00:53 UTC |
Weinberg EricChief Commercial Officer
|
PurchaseCommon Stock | 615 | $16.25 | $9,993.93 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 4 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 916 F3 · price: Represents the weighted average share price of an aggregate total of 615 shares purchased in the price range of $16.00 to $16.40 by the Reporting Person's fiance. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:52 UTC |
RxSight I, LLC10% owner
|
ConversionSeries H Preferred Stock · Derivative | 2,016,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031834 · doc4.xml · derivative · entry 2 RxSight I, LLC · CIK 0001697042 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,016,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.exercise_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.expiration_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:52 UTC |
RxSight I, LLC10% owner
|
ConversionCommon Stock | 2,016,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031834 · doc4.xml · nonDerivative · entry 1 RxSight I, LLC · CIK 0001697042 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,016,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries H Preferred Stock · Derivative | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 19 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F10 · kind: The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.exercise_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.expiration_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
Exercise / conversionSeries H Preferred Stock · Derivative | 1,452 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 18 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452 Underlying: Common Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.exercise_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.expiration_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
Exercise / conversionWarrant (right to buy) · Derivative | 1,452 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 17 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series H Preferred Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F10 · derivative.expiration_date: The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.underlying: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries H Preferred Stock · Derivative | 157,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 16 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 157,709 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.exercise_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.expiration_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries H Preferred Stock · Derivative | 9,680 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 15 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.exercise_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · derivative.expiration_date: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries G Preferred Stock · Derivative | 357,227 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 14 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 357,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · derivative.exercise_date: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · derivative.expiration_date: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries G Preferred Stock · Derivative | 42,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 13 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · derivative.exercise_date: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · derivative.expiration_date: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries F Preferred Stock · Derivative | 154,886 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 12 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 235,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F7 · price: All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F7 · derivative.exercise_date: All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F7 · derivative.expiration_date: All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries E Preferred Stock · Derivative | 18,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 11 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 22,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · derivative.exercise_date: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · derivative.expiration_date: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries E Preferred Stock · Derivative | 4,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 10 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · derivative.exercise_date: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · derivative.expiration_date: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries D Preferred Stock · Derivative | 43,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 9 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 50,711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F11 · shares: The number of shares of Series D Preferred Stock reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly allocated the number of shares directly and indirectly held. F5 · price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · derivative.exercise_date: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · derivative.expiration_date: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries D Preferred Stock · Derivative | 10,807 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 8 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,586 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F11 · shares: The number of shares of Series D Preferred Stock reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly allocated the number of shares directly and indirectly held. F5 · price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · derivative.exercise_date: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · derivative.expiration_date: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries C Preferred Stock · Derivative | 398,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 7 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 408,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F4 · price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F4 · derivative.exercise_date: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F4 · derivative.expiration_date: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries B Preferred Stock · Derivative | 246,054 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 6 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 246,054 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · derivative.exercise_date: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · derivative.expiration_date: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries B Preferred Stock · Derivative | 2,017 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 5 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,017 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · derivative.exercise_date: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · derivative.expiration_date: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries A Preferred Stock · Derivative | 11,714 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 4 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 11,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.exercise_date: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.expiration_date: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionSeries A Preferred Stock · Derivative | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · derivative · entry 3 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.exercise_date: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.expiration_date: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionCommon Stock | 1,489,805 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · nonDerivative · entry 2 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,762,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F4 · price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F7 · price: All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · ownership.nature: Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:51 UTC |
Wolfen Richard M.Director
|
ConversionCommon Stock | 76,974 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031833 · doc4.xml · nonDerivative · entry 1 Wolfen Richard M. · CIK 0001873830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F3 · price: All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F5 · price: All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F6 · price: All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F8 · price: All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F9 · price: All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:49 UTC |
Schwartz Daniel MarkDirector
|
ConversionSeries C Preferred Stock · Derivative | 3,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031831 · doc4.xml · derivative · entry 2 Schwartz Daniel Mark · CIK 0001874073 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.exercise_date: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F1 · derivative.expiration_date: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:49 UTC |
Schwartz Daniel MarkDirector
|
ConversionCommon Stock | 3,969 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031831 · doc4.xml · nonDerivative · entry 1 Schwartz Daniel Mark · CIK 0001874073 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. F2 · balance_after: The number of shares reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly overstated the number of shares held by 11,012 shares. The correct number of shares should have been reported as 403,678. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.